Webinar presentation – Misoprostol for PPH: Innovations for Impact

On December 15, MSH, Gynuity Health Projects and Jhpiego hosted a one-hour webinar to share innovations – interventions, technologies, and distribution approaches – that have the potential to increase access to and use of misoprostol for postpartum hemorrhage (PPH), the leading cause of maternal death. This webinar: Highlighted innovative ways that countries are expanding access to …

Misoprostol for postpartum hemorrhage: Empowering health workers to save lives

Shafia Rashid is a Senior Technical Advisor for the FCI Program of Management Sciences for Health. In Senegal, approximately 1,800 women lose their lives every year while giving birth. The major cause of these deaths is uncontrolled bleeding after childbirth, or postpartum hemorrhage (PPH). More than half of Senegalese women live in rural areas and …

Advocacy success story: Kenya approves misoprostol for PPH

Melissa Wanda Kirowo is advocacy project officer for FCI Program of Management Sciences for Health in Kenya.  This blog post provides an update to an earlier post. The Kenya Constitution states that every person has the right to the highest attainable standard of health, including reproductive health. To realize this right, every person must have …

Misoprostol for postpartum hemorrhage: Closing the gap between knowledge and action

By Shafia Rashid and JoAnn Paradis Shafia Rashid is Senior Technical Advisor for the FCI Program of Management Sciences for Health and JoAnn Paradis is Strategic Communications Advisor for African Strategies for Health. In many countries around the world, women give birth at home, often with only a family member or traditional birth attendant by …

Misoprostol For Postpartum Hemorrhage – A Life-Saving Technology for Maternal Health

Shafia Rashid is Senior Technical Advisor for the FCI Program of Management Sciences for Health. Available since the 1980s, the medicine misoprostol was initially marketed to prevent stomach ulcers. Health professionals eventually discovered that misoprostol also stimulates contractions of the uterus, making it useful for a number of maternal and reproductive health conditions, including postpartum …

New research calls for a different approach for misoprostol for postpartum hemorrhage

Shafia Rashid is senior program officer for the Global Advocacy program at Family Care International. Postpartum hemorrhage (PPH)—excessive, uncontrolled bleeding during or after childbirth—is the leading cause of maternal death around the world.  Despite this, the condition is almost entirely preventable and treatable. In some parts of the world, women give birth at home or …

Misoprostol for treatment of postpartum hemorrhage added to WHO Essential Medicines List

Shafia Rashid is senior program officer for Global Advocacy at Family Care International. For more than five years, FCI has been working with Gynuity Health Projects and other partners to build the evidence base for expanded availability and use of misoprostol for the prevention and treatment of postpartum hemorrhage (PPH). PPH is the leading cause …

Misoprostol for postpartum hemorrhage: translating promise into reality

By Melissa Wanda, Advocacy Officer, Family Care International – Kenya This post originally appeared on the Maternal Health Taskforce blog. In Kenya, where I work as an advocate for women’s health and rights, women continue to die during pregnancy and childbirth at alarming rates. Approximately 25% of these deaths are due to heavy bleeding following childbirth, …

Midwives and misoprostol: Saving lives from PPH

Shafia Rashid is a senior program officer for Global Advocacy at Family Care International. For women around the world, compassionate and competent care from a midwife can mean the difference between life and death. We know that midwives provide life-saving care during pregnancy, childbirth, and in the postnatal period. Midwives, and other mid-level and community …

Advocacy for Misoprostol, Advocacy for Saving Lives

By Katie Millar Katie Millar is a technical writer for the Maternal Health Task Force (MHTF), where this article originally appeared.  Hundreds of thousands of women die every year giving birth. The leading causes of these deaths—hemorrhage, infection, and eclampsia—are mostly preventable and treatable. Yet, proven treatments for these conditions are not reaching the women who …